Quintiles to Establish HQ And Expand Lab Testing Capabilities in China

Quintiles is investing $14m in a new regional headquarters in Shanghai, as well as expanding its lab testing capabilities in China.

Biopharmaceutical services company Quintiles has demonstrated its commitment to China by deciding to establish new regional headquarters in Shanghai and expand its lab testing capabilities in the country.

This investment in the emerging market was announced at a ceremony on Monday (June 18th), which was attended by company executives and local dignitaries.

Quintiles will invest $14 million in its new regional headquarters in Feng Lin Science Park, which will measure 43,000 sq ft and will serve China and other countries in Asia.

The new office will accommodate more than 450 workers in the next five years and will provide the infrastructure necessary for Quintiles' growth strategy in China.